1 hour ago
Foghorn Therapeutics (FHTX) Plummets 49% as Eli Lilly Terminates Cancer Partnership
Foghorn Therapeutics (FHTX) plunged 49% after Eli Lilly terminated their cancer drug partnership following poor Phase 1 results. Company cuts 40% of staff.
The post Foghorn Therapeutics (FHTX) Plummets 49% as Eli Lilly Terminates Cancer Partnership appeared first on Blockonomi.
Source: Blockonomi →Related News
- 11 minutes ago
OpenAI Accuses Moonshot AI of Attempting to Extract Proprietary AI Reasoning
- 21 minutes ago
NEAR Intents hit by $3.8 million exploit as crypto's rough year of hacks continu...
- 30 minutes ago
Bloomberg Terminal Introduces Comprehensive Stablecoin Tracking Dashboard
- 50 minutes ago
Court Allows Celsius Claim Against Chainalysis to Proceed in $3.3B Audit Dispute
- 1 hour ago
Veeva Systems (VEEV) Stock Poised for 30% Rally, Say Wall Street Analysts